[go: up one dir, main page]

LU87210A1 - Nouvelle composition ophtalmologique - Google Patents

Nouvelle composition ophtalmologique Download PDF

Info

Publication number
LU87210A1
LU87210A1 LU87210A LU87210A LU87210A1 LU 87210 A1 LU87210 A1 LU 87210A1 LU 87210 A LU87210 A LU 87210A LU 87210 A LU87210 A LU 87210A LU 87210 A1 LU87210 A1 LU 87210A1
Authority
LU
Luxembourg
Prior art keywords
acid
corneal
cellulose
ophthalmological composition
days
Prior art date
Application number
LU87210A
Other languages
English (en)
French (fr)
Inventor
Pierre Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of LU87210A1 publication Critical patent/LU87210A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
LU87210A 1987-05-07 1988-05-06 Nouvelle composition ophtalmologique LU87210A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8710780 1987-05-07
GB878710780A GB8710780D0 (en) 1987-05-07 1987-05-07 Opthalmological application of eicosapentaenoic acid

Publications (1)

Publication Number Publication Date
LU87210A1 true LU87210A1 (fr) 1988-12-13

Family

ID=10616936

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87210A LU87210A1 (fr) 1987-05-07 1988-05-06 Nouvelle composition ophtalmologique

Country Status (19)

Country Link
US (1) US4897421A (xx)
JP (1) JPS63297323A (xx)
KR (1) KR880013557A (xx)
AU (1) AU1567888A (xx)
BE (1) BE1001075A3 (xx)
CH (1) CH675359A5 (xx)
DE (1) DE3815581A1 (xx)
DK (1) DK250088A (xx)
FR (1) FR2614790B1 (xx)
GB (2) GB8710780D0 (xx)
IN (1) IN169811B (xx)
IT (1) IT1217446B (xx)
LU (1) LU87210A1 (xx)
MY (1) MY103079A (xx)
NL (1) NL8801125A (xx)
NZ (1) NZ224363A (xx)
OA (1) OA08843A (xx)
SE (1) SE8801710L (xx)
ZA (1) ZA882963B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657018A1 (fr) * 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
DE69004081T2 (de) * 1990-05-23 1994-02-10 Nestle Sa Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
US5444452A (en) * 1992-07-13 1995-08-22 Matsushita Electric Works, Ltd. Dual frequency antenna
DE4330664A1 (de) * 1993-09-10 1995-03-16 Beiersdorf Ag Verwendungen von Pflanzenölen
FR2722410B1 (fr) * 1994-07-15 1996-10-04 Grinda Jean Robert Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique
RU2136252C1 (ru) * 1995-01-20 1999-09-10 Вакамото Фармасьютикал Ко., Лтд. Противовоспалительные глазные капли
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
KR20030048129A (ko) * 2000-11-08 2003-06-18 산텐 세이야꾸 가부시키가이샤 파르네실초산을 유효 성분으로 하는 각결막 질환 치료제
US20070265341A1 (en) * 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
BRPI0512864B8 (pt) * 2004-07-01 2021-05-25 Johnson & Johnson Vision Care composição oftálmica, uso de pelo menos um ácido graxo ômega-6 e pelo menos um ácido graxo ômega-3 e método para preparar a referida composição
CA2611909C (en) * 2005-07-01 2014-01-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composition for treatment of corneal disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT269345B (de) * 1965-07-20 1969-03-10 Merck & Co Inc Verfahren zur Herstellung einer sterilen, von festen Teilchen freien Zubereitung für die Augenheilkunde
US3549747A (en) * 1968-02-20 1970-12-22 Flow Pharma Inc Contact lens wetting solution and method of using same
GB1340517A (en) * 1969-12-01 1973-12-12 Burton Parsons Chemicals Inc Ophthalmic solution
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
GB2020180B (en) * 1978-05-08 1982-08-25 Nelson Res & Dev Ophthalmic compositions containingcolchicine or vinblastinr
AU527784B2 (en) * 1978-05-26 1983-03-24 Bang, Hans Olaf Dr. Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
US4616012A (en) * 1983-11-25 1986-10-07 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
JPS6344843A (ja) * 1986-08-13 1988-02-25 Kao Corp 油中水中油型乳化油脂組成物

Also Published As

Publication number Publication date
MY103079A (en) 1993-04-30
DK250088D0 (da) 1988-05-06
CH675359A5 (xx) 1990-09-28
ZA882963B (en) 1988-10-28
DK250088A (da) 1988-11-08
IT1217446B (it) 1990-03-22
US4897421A (en) 1990-01-30
SE8801710L (sv) 1988-11-08
DE3815581A1 (de) 1988-11-17
GB8710780D0 (en) 1987-06-10
FR2614790B1 (fr) 1991-05-31
NL8801125A (nl) 1988-12-01
GB2204239B (en) 1990-11-28
FR2614790A1 (fr) 1988-11-10
BE1001075A3 (fr) 1989-06-27
GB2204239A (en) 1988-11-09
GB8810422D0 (en) 1988-06-08
KR880013557A (ko) 1988-12-21
OA08843A (fr) 1989-03-31
NZ224363A (en) 1990-03-27
SE8801710D0 (sv) 1988-05-05
AU1567888A (en) 1988-11-10
IT8820388A0 (it) 1988-04-29
JPS63297323A (ja) 1988-12-05
IN169811B (xx) 1991-12-28

Similar Documents

Publication Publication Date Title
LU87210A1 (fr) Nouvelle composition ophtalmologique
JPH0276819A (ja) 脂肪酸組成物
UA64797C2 (uk) Інгібітори фарнезил білок трансферази як засіб для лікування артропатії
HU229319B1 (en) Cathartic composition
JPH06501245A (ja) 高コレステロール血症の治療法
JPS6156136A (ja) 皮膚治療用局所的組成物
FR2962651A1 (fr) Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections fonctionnelles du tractus gastro-intestinal
EP0306422A1 (fr) Nouvelles formes galéniques de béta-2-mimétiques pour administration par voie per- et sublinguale
FR2962912A1 (fr) Composition pharmaceutique d'association destinee a etre utilisee dans un procede pour traiter la maladie d'alzheimer
Gunas et al. Indicators cell cycle and DNA fragmentation of spleen cells in early terms after thermal burns of skin at the background of introduction 0. 9% NaCl solution
BE895724A (fr) Nouvelle utilisation therapeutique de la dihydrocyclosporine d
FR2962655A1 (fr) Composition pharmaceutique d'association et ses utilisations dans les procedes de traitement des troubles du systeme genito-urinaire
FR2962656A1 (fr) Procede pour augmenter l'effet d'une forme activee-potentialisee d'un anticorps
TWI284529B (en) A composition for lowering triglyceride
CH651556A5 (en) Salt of (benzylindazolyl)oxyacetic acid, process for the preparation of this salt and pharmaceutical composition containing this salt
Brown et al. SPECT/CT lymphoscintigraphy of heterotopic cardiac grafts reveals novel sites of lymphatic drainage and T cell priming
FR2705569A1 (fr) Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale.
FR2987264A1 (fr) Methodes et compositions pour le traitement des metastases cancereuses
TWI323174B (en) Topical pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
JPH0118881B2 (xx)
Druet et al. Genetic control of mercury-induced immune response in the rat
FR2663543A1 (fr) Lyophilisat de potiron doux hybride et medicaments le contenant.
JP7498475B2 (ja) 多発性骨髄腫の治療剤
FR2487675A1 (fr) Nouvelles compositions pharmaceutiques injectables a base d'une phenothiazine
Robinson Presidential address. A. Some aspects of the chemotherapy of tuberculosis